INFORMED.
LIVE

Sigachi Industries Limited

BSE: SIGACHI543389ISIN INE0D0K01022
  • Healthcare
  • Pharmaceuticals
  • BSE Healthcare

Share price

₹28.10+1.57 (+5.92%)
as of 4 Nov 2026
Sigachi Industries Limited share price, 4 Nov 2025 to 4 Nov 2026: ₹36.31 to ₹28.10 (-22.6%). Low ₹17.00, high ₹37.62. Volume shown below the price.

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high
₹40.75
52W low
₹16.74
Off 52W high
-31.04%
1M return
-2.26%
3M return
+9.21%
6M return
+40.36%
1Y return
-22.61%
20D avg volume
1,14,865
50 DMA
₹29.93
200 DMA
₹24.38

Key ratios Consolidated

Market cap
₹1,074 Cr
Current price
₹28.10
52W high / low
₹40.75 / ₹16.74
Face value
₹1.00
P/E
43.72
P/B
1.99
EPS (TTM)
₹0.64
Book value / share
₹14.12
ROE
—
ROCE
-12.90%
Operating margin
—
Net margin
—
Debt / equity
0.26
Net debt
₹114.66 Cr
Interest cover
-5.31
Dividend yield
0.36%
Dividend / share (TTM)
₹0.10
Payout
15.62%
Cash conversion cycle
182.6 days

Financials

MetricQ2 FY27Q1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24
Income statement
130.46121.27121.90117.21110.48128.25128.21139.42124.9095.71104.13110.95
0.221.001.350.472.493.942.192.0214.641.687.241.71
130.68122.28123.24117.68112.98132.19130.39141.44139.5497.39111.37112.66
119.61112.19114.39118.80110.20112.18107.72114.73112.9981.0094.1693.02
46.3454.7341.6953.8742.5161.6269.5659.5664.3641.8447.5036.50
12.745.9610.905.4310.442.73-1.614.370.150.4817.2419.25
27.9828.4528.8023.6821.8419.5620.6119.4618.4115.1415.6214.00
3.853.014.333.133.133.313.333.822.103.162.871.84
4.424.414.574.184.114.724.744.673.223.153.492.82
23.8318.6717.3122.5720.8021.7928.070.950.711.010.122.06
11.0710.098.85-1.122.7820.0122.6726.7126.5516.3917.2119.64
0.000.00-1.14-0.734.66-121.010.000.000.000.000.000.00
11.0710.097.71-1.857.44-100.9922.6726.7126.5516.3917.2119.64
2.281.950.07-1.84-3.10-0.026.506.195.533.632.043.54
8.788.147.65-0.0210.53-100.9716.1720.5121.0212.7615.1716.11
0.270.180.200.010.28-2.630.360.650.660.400.480.51
Key metrics
19.3417.5116.615.4614.68-92.9630.7435.2031.8722.7023.5724.30
14.80%14.40%13.60%4.70%13.30%-72.50%24.00%25.20%25.50%23.70%22.60%21.90%
6.70%6.70%6.30%0.00%9.50%-78.70%12.60%14.70%16.80%13.30%14.60%14.50%
2.50%—2.10%—1.90%—3.90%—————
18.10%-5.40%-4.90%-15.90%-11.50%34.00%23.10%25.70%————
-16.60%108.10%-52.70%-100.10%-49.90%-891.30%6.60%27.30%————
MetricTTMFY26FY25FY24FY23FY22
Income statement
490.84477.83488.24398.96302.05250.29
3.048.2520.5211.696.672.63
493.88486.08508.76410.64308.72252.92
464.99455.57416.44340.87254.24201.32
196.63199.68235.32160.30140.99123.47
35.0329.503.0939.971.37—
108.91110.3873.6257.1638.2521.08
14.3213.9012.417.774.291.17
17.5817.5815.7810.806.622.90
82.3865.9892.513.882.8857.57
28.8930.5292.3269.7754.4851.60
-1.87-118.210.000.000.000.00
27.02-87.7092.3269.7754.4851.60
2.46-4.8921.8612.5110.9411.56
24.55-82.8170.4657.2743.5440.04
0.66-2.142.061.8114.1615.44
Key metrics
58.92-56.22120.5188.3465.3955.67
12.00%-11.80%24.70%22.10%21.60%22.20%
5.00%-17.30%14.40%14.40%14.40%16.00%
—-12.90%15.80%———
-3.07%-2.10%22.40%32.10%20.70%—
—-217.50%23.00%31.50%8.70%—
—-36.87-16.40———
—-0.050.38———
—0.260.23———
—114.66124.88———
—182.6181.1———
Balance sheet
—841.17846.21———
—389.35394.33———
—20.9017.28———
—224.20183.67———
—73.5994.27———
—23.6317.64———
—239.77287.64———
—58.8035.65———
—270.47185.12———
—135.56142.16———
—135.56120.55———
—0.0021.61———
—528.88613.08———
Cash flow
—4.3026.93———
—-52.55-93.07———
—2.2481.10———
—41.1743.33———
MetricQ2 FY27Q1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24
Income statement
113.4898.2892.1092.0383.94110.98113.54105.08109.0880.1483.6676.83
0.220.441.330.472.493.941.772.0514.581.687.171.69
113.7098.7293.4292.5086.44114.92115.31107.12123.6681.8190.8278.52
103.1990.9386.6290.7683.1293.11101.5991.2095.2769.0973.8364.76
44.2644.5431.0146.0736.2357.2256.6445.4257.1432.4838.1733.14
7.724.027.060.602.631.051.614.370.163.451.000.13
25.1623.2824.2819.1417.2315.0915.3315.0214.5612.6411.8812.31
3.162.192.942.522.532.152.803.361.612.882.431.67
3.623.623.783.383.313.953.943.962.552.482.722.06
19.1615.9612.2219.4618.1319.0523.980.480.410.380.730.46
10.517.796.801.743.3221.8013.7215.9228.3912.7216.9913.76
0.000.00-1.14-0.734.66-121.010.00—————
10.517.795.671.017.97-99.2013.7215.9228.3912.7216.9913.76
1.541.290.76-1.92-3.790.066.756.246.673.445.262.99
8.986.514.912.9311.76-99.146.989.6821.729.2911.7310.77
0.230.170.130.080.31-2.590.180.290.660.280.370.34
Key metrics
17.2913.6012.396.9113.81-93.1020.4623.2432.5518.0822.1417.49
15.20%13.80%13.50%7.50%16.50%-83.90%18.00%22.10%29.80%22.60%26.50%22.80%
7.90%6.60%5.30%3.20%14.00%-89.30%6.10%9.20%19.90%11.60%14.00%14.00%
2.60%—1.70%—2.10%—2.70%—————
35.20%-11.40%-18.90%-12.40%-23.00%38.50%35.70%36.80%————
-23.60%106.60%-29.70%-69.70%-45.90%-1,167.20%-40.50%-10.10%————
MetricTTMFY26FY25FY24FY23FY22
Income statement
395.89379.04407.83317.50290.32249.41
2.468.2320.0811.576.672.63
398.34387.27427.91329.07297.00252.03
371.50353.61357.15273.94245.42203.07
165.88170.54191.67141.92137.72119.37
19.4011.356.054.611.37—
91.8692.2557.5549.1636.0020.02
10.8110.1310.667.024.291.16
14.4014.4312.928.716.622.90
66.8052.3681.012.572.5256.39
26.8433.6670.7655.1451.5848.97
-1.87-118.210.00———
24.98-84.5570.7655.1451.5848.97
1.67-5.0023.0914.1210.0210.94
23.33-79.5547.6741.0141.5638.03
0.61-2.081.411.3013.5214.66
Key metrics
50.19-59.9994.3470.8762.4953.03
12.68%-15.80%23.10%22.30%21.50%21.30%
5.89%-21.00%11.70%12.90%14.30%15.20%
—-14.50%13.50%———
-4.27%-7.10%28.50%9.40%16.40%—
—-266.90%16.20%-1.30%9.30%—
—3.47-5.92———
—-0.550.75———
—0.210.16———
—86.6079.04———
—108.7124.9———
Balance sheet
—724.71745.97———
—253.45314.36———
—12.889.47———
—123.51134.18———
—34.0038.10———
—20.6313.97———
—180.24225.98———
—44.5732.70———
—209.93143.33———
—99.4888.51———
—99.4888.51———
—0.000.00———
—475.90559.66———
Cash flow
—43.6235.62———
—-89.30-90.31———
—-0.5269.61———
—40.1541.54———

Compounded growth

Standalone

Sales CAGR 3Y
+9.30%
Sales CAGR 5Y
—
Profit CAGR 3Y
—
Profit CAGR 5Y
—
Sales YoY (TTM)
-4.27%
Profit YoY (TTM)
+132.99%

Consolidated

Sales CAGR 3Y
+16.52%
Sales CAGR 5Y
—
Profit CAGR 3Y
—
Profit CAGR 5Y
—
Sales YoY (TTM)
-3.07%
Profit YoY (TTM)
+145.67%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding
36.67%
QuarterSeptember 2026June 2026
Promoter %36.67%36.67%
HolderTypeHoldingPreviousChange
RPS INDUSTRIES PRIVATE LIMITEDPromoter15.02%15.02%0.00%
CHIDAMBARNATHAN SHANMUGANATHANPromoter5.08%5.08%0.00%
RABINDRA PRASAD SINHAPromoter3.99%3.99%0.00%
AMIT RAJ SINHAPromoter3.66%3.66%0.00%
RAKESH YADAVPublic2.65%2.65%0.00%
SWATI SINHAPromoter Group2.36%2.36%0.00%
DHARANI DEVI CHIDAMBARANATHAMPromoter Group1.67%1.67%0.00%
NITIN RAJ SINHAPromoter Group1.67%1.67%0.00%
MAHESHWARI VIJAYBHAI BHAVSARPublic1.29%1.30%-0.01%
SUDHIR YADAVPublic1.23%1.23%0.00%
RPS FAMILY TRUSTPromoter Group1.21%1.21%0.00%
SMITA SINHAPromoter Group0.81%0.81%0.00%
AMIT RAJ SINHA FAMILY TRUSTPromoter Group0.78%0.78%0.00%
SUDHA SINHAPromoter Group0.22%0.22%0.00%
BIMLA SHARMAPromoter Group0.12%0.12%0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

CompanyMkt cap (₹ Cr)Price (₹)P/EROCESales YoYProfit YoY1Y return
Sun Pharmaceutical Industries Ltd.4,26,1121,776.0038.7817.90%+12.13% TTM+4.79% TTM+4.92%
Divi's Laboratories Ltd.2,66,42410,036.0091.0919.00%+16.35% TTM+26.84% TTM+47.61%
Torrent Pharmaceuticals Ltd.1,79,9084,730.0085.719.10%+42.06% TTM-1.92% TTM+32.24%
Laurus Labs Limited1,24,6012,306.1093.5319.70%+23.03% TTM+95.38% TTM+134.59%
Zydus Lifesciences Limited1,18,7031,190.0025.8519.20%+21.11% TTM-2.51% TTM+22.32%
Dr. Reddy's Laboratories Ltd.1,14,5131,372.0041.5013.90%-3.53% TTM-51.90% TTM+14.26%
Cipla Ltd.1,13,1101,400.1039.6314.90%-0.74% TTM-47.48% TTM-6.88%
Mankind Pharma Limited1,04,6312,533.1546.2213.70%+13.27% TTM+27.60% TTM+6.91%
Aurobindo Pharma Ltd.97,8781,701.1026.3813.60%+9.09% TTM+9.48% TTM+47.79%
Lupin Ltd92,1452,015.0017.6528.40%+24.22% TTM+20.10% TTM+0.84%
Glenmark Pharmaceuticals ltd70,6082,501.8539.2716.20%+32.94% TTM+138.48% TTM+35.48%
Alkem Laboratories Limited62,0545,190.0028.1518.80%+13.36% TTM-5.52% TTM-8.38%
Abbott India Ltd. S57,68527,146.8535.7341.90%+6.29% TTM+11.18% TTM-7.56%
Biocon Ltd.56,061344.00134.632.90%+5.70% TTM-55.37% TTM-9.53%
Gland Pharma Limited52,1053,157.7046.1613.70%+17.57% TTM+46.55% TTM+65.09%
Ipca Laboratories Ltd.50,0511,973.1536.4016.40%+10.59% TTM+67.91% TTM+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.42,9042,532.6037.4255.40%+12.12% TTM+20.03% TTM-4.84%
Ajanta Pharma Ltd.41,4063,313.5532.7929.40%+25.01% TTM+29.70% TTM+26.89%
Emcure Pharmaceuticals Limited41,2542,174.5537.7525.10%+21.12% TTM+33.34% TTM+64.07%
J.B. Chemicals & Pharmaceuticals Lt38,7312,412.2547.7721.90%+5.87% TTM+7.56% TTM+45.79%
Sai Life Sciences Limited32,8551,546.3090.8018.10%——+67.49%
PIRAMAL PHARMA LIMITED31,659237.80-151.210.80%+9.43% TTM-781.93% TTM+18.60%
ACUTAAS CHEMICALS LIMITED30,9283,777.6570.5127.70%+45.18% TTM+95.78% TTM+106.30%
Wockhardt Ltd30,8691,899.8076.226.40%+25.70% TTM+894.12% TTM+39.18%
RUBICON RESEARCH LIMITED28,4161,716.5598.5924.30%——+164.06%
Sigachi Industries Limited1,07428.1043.72-12.90%-3.07% TTM+145.67% TTM-22.61%

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 0.100022 Sep 202622 Sep 2026—
Final Dividend - Rs. - 0.100016 Sep 202516 Sep 2025—
Final Dividend - Rs. - 0.100028 Aug 2024——

Board meetings

  • Board Meeting - Financial Results
  • Board Meeting - Financial Results
  • Board Meeting - Financial Results